GRMRX
Price
$31.10
Change
+$0.32 (+1.04%)
Updated
Oct 20 closing price
Net Assets
1.72B
VSTSX
Price
$317.21
Change
+$3.54 (+1.13%)
Updated
Oct 20 closing price
Net Assets
2.02T
Interact to see
Advertisement

GRMRX vs VSTSX

Header iconGRMRX vs VSTSX Comparison
Open Charts GRMRX vs VSTSXBanner chart's image
Nationwide S&P 500 Index R
Price$31.10
Change+$0.32 (+1.04%)
VolumeN/A
Net Assets1.72B
Vanguard Total Stock Mkt Idx Instl Sel
Price$317.21
Change+$3.54 (+1.13%)
VolumeN/A
Net Assets2.02T
GRMRX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
GRMRX vs. VSTSX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRMRX is a Hold and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.02T vs. GRMRX (1.73B). VSTSX pays higher dividends than GRMRX: VSTSX (1.15) vs GRMRX (0.39). GRMRX was incepted earlier than VSTSX: GRMRX (19 years) vs VSTSX (9 years). GRMRX (0.93) is less costly to investors than VSTSX (0.01). GRMRX is a more actively managed with annual turnover of: 3.07 vs. VSTSX (2.00). GRMRX has a lower initial minimum investment than VSTSX: GRMRX (0) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 14.67 vs. GRMRX (12.14). VSTSX (89.91) and GRMRX (85.93) have equivalent 5 years return.
GRMRXVSTSXGRMRX / VSTSX
Total Expense Ratio0.930.019,300%
Annual Report Gross Expense Ratio0.930.019,300%
Fund Existence19 years9 years-
Gain YTD13.67314.30596%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.73B2.02T0%
Annual Yield % from dividends0.391.1534%
Returns for 1 year12.1414.6783%
Returns for 3 years75.7777.0998%
Returns for 5 years85.9389.9196%
Returns for 10 years116.75N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FDMT11.271.43
+14.53%
4D Molecular Therapeutics
INDP3.900.20
+5.41%
Indaptus Therapeutics Inc
APPN29.211.06
+3.77%
Appian Corp
LGO1.330.04
+3.10%
Largo
IONS73.550.46
+0.63%
Ionis Pharmaceuticals